International Journal of Hematology and Oncology 2023, Vol 33, Num 4 Page(s): 090-095
CENTRAL VENOUS ACCESS SYSTEM COMPLICATIONS IN PATIENTS WITH SOLID TUMORS

İLHAN ÖZTOP1, TUĞBA YAVUZŞEN1, UĞUR YILMAZ1, CANER ÇAVDAR1, ARZU YAREN1, OKTAY TARHAN1, NEZİH MEYDAN1, SELMAN SÖKMEN1, TANER ÇAMSARI1, MEHMET ALAKAVUKLAR1

Dokuz Eylül Üniv. Onkoloji Enstitüsü

Keywords: solid tumor, central venous catheter, complication
To evaluate the efficacy and complications of central venous access systems in patients with solid tumors. External and implantable central venous catheters were implanted in patients who would receive chemotherapy for cancer. All data such as the patient's age, performance status, tumor type, stage, comorbidity, type of chemotherapy and catheter, catheter duration and early and late complications were collected. Totally, 114 central venous catheters were implanted to 112 patients who had various solid tumors. Most of the patients (82/112, 73.2%) had colorectal cancer. Totally 101 (88.6%) external and 13 (11.4%) implantable central venous catheters were used. The median follow-up was 157.7±64.6 days with a total of 18342 days. Complications were observed in 15 (13.1%) of 114 catheters, and 13 of them were external catheters. Six and 9 complications were early and late complications respectively. The most frequent complication observed in whole group was malfunction. The total complication rate was 0.076/100 days. The central venous catheters are the venous access systems which facilitate the treatment with a rate of low complication in patients with solid tumors.